Is it Time to Enhance Assessment of Alcohol Intake in Patients Slated for Statin Therapy?

Edmond Kato Kabagambe, Sergio Fazio

    Research output: Contribution to journalReview article

    2 Citations (Scopus)

    Abstract

    Use of statins significantly lowers low-density lipoprotein cholesterol levels, resulting in substantial reduction in cardiovascular event rates. Despite this great achievement, cardiovascular risk remains high, especially among the elderly (>65 years) and those with conditions such as diabetes and kidney disease. It is thus crucial to identify variables that modulate effectiveness and efficacy of statin therapy. Alcohol, a common dietary component, is widely consumed at varying amounts and often concomitantly with statin therapy. Since moderate alcohol consumption is associated with cardiovascular benefits while heavy intake increases risk for ill health, it is possible that moderate alcohol may enhance benefits from statins while heavy alcohol could diminish or even abrogate such benefits. Whether this is true remains unknown. In this commentary we present pathways through which alcohol may impact use and response to statins and suggest that enhancing screening for alcohol abuse among patients slated for statin therapy may improve therapeutic outcomes.

    Original languageEnglish (US)
    JournalCurrent Nutrition Reports
    Volume4
    Issue number1
    DOIs
    StatePublished - Jan 1 2015

    Fingerprint

    Hydroxymethylglutaryl-CoA Reductase Inhibitors
    alcohols
    Alcohols
    therapeutics
    Therapeutics
    alcohol abuse
    kidney diseases
    low density lipoprotein cholesterol
    diabetes
    Kidney Diseases
    screening
    Alcohol Drinking
    LDL Cholesterol
    Alcoholism
    alcohol drinking
    Health

    Keywords

    • Alcohol
    • Cardiovascular disease
    • Drug interactions
    • Lipids
    • Statins

    ASJC Scopus subject areas

    • Food Science
    • Nutrition and Dietetics

    Cite this

    Is it Time to Enhance Assessment of Alcohol Intake in Patients Slated for Statin Therapy? / Kabagambe, Edmond Kato; Fazio, Sergio.

    In: Current Nutrition Reports, Vol. 4, No. 1, 01.01.2015.

    Research output: Contribution to journalReview article

    @article{99088d9937264b91ba700218fa7b1ec9,
    title = "Is it Time to Enhance Assessment of Alcohol Intake in Patients Slated for Statin Therapy?",
    abstract = "Use of statins significantly lowers low-density lipoprotein cholesterol levels, resulting in substantial reduction in cardiovascular event rates. Despite this great achievement, cardiovascular risk remains high, especially among the elderly (>65 years) and those with conditions such as diabetes and kidney disease. It is thus crucial to identify variables that modulate effectiveness and efficacy of statin therapy. Alcohol, a common dietary component, is widely consumed at varying amounts and often concomitantly with statin therapy. Since moderate alcohol consumption is associated with cardiovascular benefits while heavy intake increases risk for ill health, it is possible that moderate alcohol may enhance benefits from statins while heavy alcohol could diminish or even abrogate such benefits. Whether this is true remains unknown. In this commentary we present pathways through which alcohol may impact use and response to statins and suggest that enhancing screening for alcohol abuse among patients slated for statin therapy may improve therapeutic outcomes.",
    keywords = "Alcohol, Cardiovascular disease, Drug interactions, Lipids, Statins",
    author = "Kabagambe, {Edmond Kato} and Sergio Fazio",
    year = "2015",
    month = "1",
    day = "1",
    doi = "10.1007/s13668-014-0107-1",
    language = "English (US)",
    volume = "4",
    journal = "Current Nutrition Reports",
    issn = "2161-3311",
    publisher = "Springer New York",
    number = "1",

    }

    TY - JOUR

    T1 - Is it Time to Enhance Assessment of Alcohol Intake in Patients Slated for Statin Therapy?

    AU - Kabagambe, Edmond Kato

    AU - Fazio, Sergio

    PY - 2015/1/1

    Y1 - 2015/1/1

    N2 - Use of statins significantly lowers low-density lipoprotein cholesterol levels, resulting in substantial reduction in cardiovascular event rates. Despite this great achievement, cardiovascular risk remains high, especially among the elderly (>65 years) and those with conditions such as diabetes and kidney disease. It is thus crucial to identify variables that modulate effectiveness and efficacy of statin therapy. Alcohol, a common dietary component, is widely consumed at varying amounts and often concomitantly with statin therapy. Since moderate alcohol consumption is associated with cardiovascular benefits while heavy intake increases risk for ill health, it is possible that moderate alcohol may enhance benefits from statins while heavy alcohol could diminish or even abrogate such benefits. Whether this is true remains unknown. In this commentary we present pathways through which alcohol may impact use and response to statins and suggest that enhancing screening for alcohol abuse among patients slated for statin therapy may improve therapeutic outcomes.

    AB - Use of statins significantly lowers low-density lipoprotein cholesterol levels, resulting in substantial reduction in cardiovascular event rates. Despite this great achievement, cardiovascular risk remains high, especially among the elderly (>65 years) and those with conditions such as diabetes and kidney disease. It is thus crucial to identify variables that modulate effectiveness and efficacy of statin therapy. Alcohol, a common dietary component, is widely consumed at varying amounts and often concomitantly with statin therapy. Since moderate alcohol consumption is associated with cardiovascular benefits while heavy intake increases risk for ill health, it is possible that moderate alcohol may enhance benefits from statins while heavy alcohol could diminish or even abrogate such benefits. Whether this is true remains unknown. In this commentary we present pathways through which alcohol may impact use and response to statins and suggest that enhancing screening for alcohol abuse among patients slated for statin therapy may improve therapeutic outcomes.

    KW - Alcohol

    KW - Cardiovascular disease

    KW - Drug interactions

    KW - Lipids

    KW - Statins

    UR - http://www.scopus.com/inward/record.url?scp=84930817153&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84930817153&partnerID=8YFLogxK

    U2 - 10.1007/s13668-014-0107-1

    DO - 10.1007/s13668-014-0107-1

    M3 - Review article

    VL - 4

    JO - Current Nutrition Reports

    JF - Current Nutrition Reports

    SN - 2161-3311

    IS - 1

    ER -